Johnson Investment Counsel’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,995
Closed -$414K 864
2025
Q4
$414K Sell
6,995
-506
-7% -$27.5K ﹤0.01% 600
2025
Q3
$414K Hold
7,501
﹤0.01% 621
2025
Q2
$323K Hold
7,501
﹤0.01% 651
2025
Q1
$297K Sell
7,501
-37
-0.5% -$1.64K ﹤0.01% 646
2024
Q4
$307K Buy
7,538
+628
+9% +$26.2K ﹤0.01% 644
2024
Q3
$269K Buy
6,910
+1,984
+40% +$79K ﹤0.01% 671
2024
Q2
$215K Hold
4,926
﹤0.01% 699
2024
Q1
$235K Buy
+4,926
New +$221K ﹤0.01% 666

Other funds holding NGVT

Johnson Investment Counsel's NGVT Position: Q1 2026 in Review

Johnson Investment Counsel sold out of Ingevity (NGVT) in Q1 2026, closing a stake of 6,995 shares — an estimated $414K sold.

Johnson Investment Counsel first reported a position in NGVT in Q1 2024 and held it in 8 quarters. The position peaked at $414K in Q3 2025. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • Johnson Investment Counsel reported no remaining Ingevity position as of Q1 2026 after selling out during the quarter.
  • Johnson Investment Counsel sold 6,995 Ingevity shares in Q1 2026, an estimated $414K.
  • Johnson Investment Counsel first reported a position in Ingevity in Q1 2024 and held it in 8 quarters.
  • Johnson Investment Counsel's Ingevity position peaked at $414K in Q3 2025.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Johnson Investment Counsel's 13F filing for Q1 2026, filed 4 May 2026.